Non-Small Cell Lung Cancer

When you come to us for diagnosis or treatment for non-small cell lung cancer, you can typically see each member of our group on the same day. Your team may include pulmonologists, thoracic surgeons, medical oncologists, radiation oncologists, and interventional radiologists. This multidisciplinary team of internationally renowned experts creates a treatment plan that’s customized for you.

We use a variety of tests on tissue and blood to learn as much about the lung cancer as possible, helping us create the best treatment plan for you.

Our clinical trials can provide the newest therapeutic options, such as targeted drugs and immunotherapy. We also offer many supportive services, such as lung rehabilitation, psychological care, and integrative health therapies.

Clinical Trials and Research Studies

Phase 1

Phase 1b Open-label Study of MK-7162 in Combination with Pembrolizumab (MK-3475) +/- other therapies in Participants with Advanced Solid Tumors

Learn More

Phase 1

A Phase 1 Open-Label Multicenter Study to Assess the Safety Tolerability and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors

Learn More

Phase 1/2

A Phase 1-2 Open-Label Dose-Finding Proof of Concept First-in-Human Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CX-2009 in Adults with Metastatic or Locally Advanced Unresectable Solid Tumors

Learn More

Phase 1/2

A Phase I/IIa Study of BMS-986205 Administered in Combination with Nivolumab (BMS-935558 anti-PD-1 Monoclonal Antibody) in Advanced Malignant Tumors

Learn More